Main menu

The visit by HRH Crown Princess Mary for the renaming of the Centre was a tribute to the quality of the work we do

Our patients enjoy a panoramic view during radiation therapy treatment

Health in our hands – treating our patients with compassion, dignity and respect
and gaining a better understanding of their needs

For decades the facility at Westmead has been a leading Australian centre for treatment, teaching and research.

Multi-Disciplinary Team Care Approach: Wouldn't you prefer it if all of your specialists were talking to each other,
deciding on the best treatment for you?

Translational cancer research, sees researchers working very closely with clinicians
to improve outcomes for our patients

The Crown Princess Mary Cancer Centre Westmead
Internationally accredited as a ESMO Designated Center of Integrated Oncology and Palliative Care

Introducing Professor Anna deFazio, Sydney West Chair in Translational Cancer Research
who is pioneering groundbreaking research into ovarian cancer.

Care Coordinators - dedicated to helping in all aspects of disease treatment and side-effects.

ABOUT OUR RESEARCH

researcherA groundbreaking new $6.5 million cancer research centre was established in western Sydney in 2011 to drive improvements in patient care.The Sydney-West Translational Cancer Research Centre (TCRC) has put the west of Sydney on the map as a hub  for world-class cancer research, improving the links between research and clinical care.

 

The Sydney-West TCRC links multidisciplinary teams from the Sydney West Cancer Network, cancer research groups of the Westmead Millennium Institute for Medical Research, the Westmead node of the Melanoma Institute Australia, and other affiliated clinical and research groups involved in cancer care in the west of Sydney.

 

This is a hugely exciting development for western Sydney. It will create a connected professional community of cancer researchers and clinicians who are committed to the common goals of excellence in cancer research and evidence-based clinical practice.

A/Professor Paul Harnett, Director Sydney West Cancer Network

Sydney West Translational Cancer Research Centre

Our People

Our People

Director

Clinical Associate Professor Paul Harnett - Medical Oncologist, Director, Sydney West Cancer Network

Associate Director

Clinical Associate Professor Rosemary Balleine, Clinical Director, Tissue Pathology and Diagnostic Oncology

Executive Council
  • Professor Rick Kefford - Medical Oncologist, Director, Westmead Institute for Cancer Research, Co-Director of Research, Melanoma Institute of Australia
  • Professor Jacob George - Gastroenterologist/Hepatologist, Director, WMI Storr Liver Unit
  • Professor David Gottlieb - Haematologist, Director, Cellular Therapies Unit, WICR Research Group Leader
  • Professor Anna deFazio - Research Scientist, Sydney West Chair in Translational Cancer Research, WICR Research Group Leader
  • Dr Peter Flynn, Thoracic Surgeon, Executive Medical Director, Nepean Hospital
Manager

Ms Pamela Provan

Research Support Officer

Dr Karin Lyon

Translational Cancer Research Fellows

Dr Dhanusha Sabanathan

Dr  Maria Najim

Dr Ming-Celine Dubosq

Educational Research Fellow

Dr Tracy Robinson

Our Vision

The Sydney West Translational Cancer Research Centre vision is to create a dynamic, professional community across multiple locations and disciplines that are connected in real-time through an interactive information technology network.

Our overall goal is to enhance current and future translational cancer medicine through a range of initiatives that will:

  • Create a connected professional community of cancer research and practice in western Sydney.
  • Embed research as one of the core disciplines contributing to the Multi Disciplinary Team (MDT) based approach to cancer care.
  • Provide support, training and development of the cancer workforce.
  • Implement and evaluate the impact of strategies to disseminate knowledge and effect practice change in the broader clinical community.

How you can help us

Continued cancer research is vital as it helps build our knowledge and understanding of the different types of cancer. It helps us to better understand this terrible disease.  Through this research we are continually improve ways of detecting and diagnosing cancer and have developed more targeted cancer treatments and improved patient care. Click here to make a donation to "Cancer Research"

Contacts

The Sydney West Translational Cancer Research Centre management group is located within the Crown Princess Mary Cancer Centre Westmead, Westmead Hospital.

Please direct all enquiries to the manager:

Pamela Provan  

Ph: +61 2 9845 9561
Fx: +61 2 9845 6391
Em: pamela.provan@sydney.edu.au

Office Location

Crown Princess Mary Cancer Centre Westmead
Westmead Hospital
Westmead NSW 2145

Postal Address

Sydney West Translational Cancer Research Centre
Crown Princess Mary Cancer Centre Westmead
Westmead Hospital
PO Box 533
Wentworthville NSW 2145

WMI artist impression

New home for the Westmead Millennium Institute for Medical Research

WICR logo

The Westmead Institute for Cancer Research, located at Westmead Millennium Institute,

Westmead Institute for Cancer Research (WICR) conducts research into the molecular and cellular basis of human cancer (breast cancer, melanoma and other skin cancers, ovarian cancer and bowel cancer) and leukaemia. The research of WICR is focused on understanding cell growth, cell defences against cancer-causing DNA toxins, immunological defence against cancer, the relationships between viruses and cancer, and the genetic foundations of the disease.

Researchers at WICR were a major partner in the matching and characterisation of the genes that make people susceptible to melanoma. In addition, the unit has shown new ways that hormones regulate breast cancers, and the familial cancer laboratory is one the main centres for Australian collaborative work on the genes that make women susceptible to breast cancer. Research groups within the Westmead Institute for Cancer Research include:

  • Breast Cancer, led by Professor Christine Clarke
  • Familial Cancer, led by A/Prof Judy Kirk
  • Gene Expression, led by Dr Beric Henderson
  • Gynaecological Oncology, led by Dr Anna deFazio
  • Leukaemia Cell Biology, led by Dr Linda Bendall
  • Leukaemia Cell Therapies, led by Professor David Gottlieb
  • Melanoma Program – Genomics & Genetics Epidemiology Research Team, led by Professor Graham Mann
  • Translational Oncology, led by Dr Rosemary Balleine

Visit us on Facebook